Bone Marrow TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone MarrowMultiple MyelomaBone Marrow CellsCombined Modality TherapyGraft vs Host DiseaseTransplantation ConditioningTreatment OutcomeRecurrenceStem CellsAntineoplastic Combined Chemotherapy ProtocolsRemission InductionWhole-Body IrradiationMelphalanHematopoietic Stem CellsThalidomideAmyloidosisBone Marrow PurgingPeripheral Blood Stem Cell TransplantationBoronic AcidsPyrazinesGraft SurvivalCyclophosphamideBusulfanHematologic NeoplasmsTissue DonorsAnemia, AplasticBone and BonesLeukemiaLymphoma, Non-HodgkinSalvage TherapyTransplantation ChimeraHistocompatibility TestingHodgkin DiseaseHematopoietic Stem Cell MobilizationDisease-Free SurvivalRetrospective StudiesHistocompatibilityEtoposideKidney TransplantationTime FactorsSurvival AnalysisSurvival RateCarmustineCytarabineImmunosuppressive AgentsLiver TransplantationTransplantationLeukemia, Myeloid, AcuteHematopoiesisThiotepaCytomegalovirus InfectionsFollow-Up StudiesMyeloablative AgonistsAntigens, CD34VincristineGraft RejectionTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGranulocyte Colony-Stimulating FactorHepatic Veno-Occlusive DiseaseCell DifferentiationLeukemia, MyeloidPrognosisAcute DiseaseMice, Inbred C57BLBone Marrow DiseasesImmunocompromised HostLymphomaMyelodysplastic SyndromesImmunosuppressionOpportunistic InfectionsT-LymphocytesHematologic DiseasesFatal OutcomeMesenchymal Stem Cell TransplantationHeart TransplantationRadiation ChimeraLymphocyte DepletionTransplantation ImmunologyLeukocyte TransfusionEmbryonic Stem CellsLymphoma, FollicularCells, CulturedHLA AntigensDexamethasoneCyclosporineBone Marrow ExaminationFlow CytometryAdult Stem CellsLung TransplantationColony-Forming Units AssayProspective StudiesDoxorubicinPodophyllotoxin